TRAVAMINE TAB 50MG 50 MG — DIN 00272671
DIMENHYDRINATE : 50 MG · ICN CANADA LTD. · TABLET · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is TRAVAMINE TAB 50MG?
TRAVAMINE TAB 50MG 50 MG contains DIMENHYDRINATE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 00272671, held by ICN CANADA LTD., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 04-May-2005. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Dimenhydrinate in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
35 holders have a Canadian DIN containing Dimenhydrinate, across 70 DINs, of which 20 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| CHURCH & DWIGHT CANADA CORP | 15 | 8 | GRAVOL CAPSULES LONG ACTING 75MG, GRAVOL CHEWABLES, GRAVOL FILMKOTE TAB 15MG, GRAVOL IM, GRAVOL IMMEDIATE RELEASE & LONG ACTING CAPLETS, +10 more | Sourceable in Canada |
| SANDOZ CANADA INCORPORATED | 5 | 3 | DIMENHYDRINATE INJECTION USP, NAUSEATOL | Sourceable in Canada |
| VITA HEALTH PRODUCTS INC | 3 | 3 | ANTI-NAUSEANT, ANTI-NAUSEANT LIQUID GELS, TRAVEL TABS 50 MG | Sourceable in Canada |
| HIKMA CANADA LIMITED | 2 | 2 | DIMENHYDRINATE INJECTION USP | Sourceable in Canada |
| LABORATOIRES CONFAB INC | 2 | 2 | CONFAB DIMENHYDRINATE 100 MG, CONFAB DIMENHYDRINATE 50 MG | Sourceable in Canada |
| MEDTECH PRODUCTS INC | 3 | 1 | DRAMAMINE, DRAMAMINE MOTION SICKNESS RELIEF, GAVISCON NAUSEA | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 1 | 1 | JAMP-DIMENHYDRINATE | Sourceable in Canada |
| PHARMASCIENCE INC | 4 | 0 | ANTI-NAUSEANT, PMS-DIMENHYDRINATE SYR 3MG/ML, PMS-DIMENHYDRINATE TAB 50MG | No marketed DIN |
| TANTA PHARMACEUTICALS INC | 4 | 0 | CHILDREN'S MOTION SICKNESS LIQ, DIMENHYDRINATE TABLETS, MOTION SICKNESS CHILDREN'S CHEWABLE TABLETS, TRAVEL TABS | No marketed DIN |
| APOTEX INC | 3 | 0 | ANTI-NAUSEANT, APO DIMENHYDRINATE TAB 50MG, DIMENHYDRINATE CAPSULES | No marketed DIN |
| ICN CANADA LTD. | 2 | 0 | TRAVAMINE SUP 50MG, TRAVAMINE TAB 50MG | No marketed DIN |
| STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | 2 | 0 | ANTI-NAUSEANT TABLET, TRAVELTABS 50MG | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 50 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Dimenhydrinate |
|---|---|
| ATC code | R06AA11 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00272671 |
|---|---|
| DIN (unpadded, as printed on some documents) | 272671 |
| Brand name | TRAVAMINE TAB 50MG |
| Generic / active ingredient | DIMENHYDRINATE : 50 MG |
| Market authorization holder | ICN CANADA LTD. |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R06AA11 |
| ATC anatomical main group | R — Respiratory system |
| ATC therapeutic subgroup | R06AA |
| Current status | CANCELLED POST MARKET |
| Status date | 04-May-2005 |
| Original market date | 1973-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
20 of 70 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ANTI-NAUSEANT | 50 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | 02241532 |
| ANTI-NAUSEANT LIQUID GELS | 50 MG | CAPSULE | VITA HEALTH PRODUCTS INC | MARKETED | 02493004 |
| CONFAB DIMENHYDRINATE 100 MG | 100 MG | SUPPOSITORY | LABORATOIRES CONFAB INC | MARKETED | 00392545 |
| CONFAB DIMENHYDRINATE 50 MG | 50 MG | SUPPOSITORY | LABORATOIRES CONFAB INC | MARKETED | 00392553 |
| DIMENHYDRINATE INJECTION USP | 50 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | 02536536 |
| DIMENHYDRINATE INJECTION USP | 50 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | 00392537 |
| DIMENHYDRINATE INJECTION USP | 50 MG / 1 ML | SOLUTION | HIKMA CANADA LIMITED | MARKETED | 02428954 |
| DIMENHYDRINATE INJECTION USP | 10 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | 00392731 |
| DIMENHYDRINATE INJECTION USP | 250 MG / 5 ML | SOLUTION | HIKMA CANADA LIMITED | MARKETED | 02435241 |
| GAVISCON NAUSEA | 50 MG | TABLET | MEDTECH PRODUCTS INC | MARKETED | 02490528 |
2 · Same class — other molecules in ATC R06AA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Diphenhydramine | AG-DIPHENHYDRAMINE 25 MG · AG-DIPHENHYDRAMINE 50 MG · ALLER-AIDE · ALLER-AIDE ELIXIR · +155 more | 183 | 51 | Yes |
| Dimenhydrinate | AG-DIMENHYDRINATE · ANTI-NAUSEANT · ANTI-NAUSEANT LIQUID GELS · ANTI-NAUSEANT TABLET · +56 more | 70 | 20 | Yes |
| Doxylamine, Combinations | ALOG-DOXYLAMINE/PYRIDOXINE · APO-DOXYLAMINE/B6 · DICLECTIN · PMS-DOXYLAMINE-PYRIDOXINE · +1 more | 5 | 4 | Yes |
| Diphenhydramine, Combinations | BENADRYL ALLERGY & SINUS · BUCKLEY'S NIGHTTIME COUGH & CONGESTION | 2 | 1 | Yes |
| Clemastine | TAVIST TABLETS 1MG | 1 | 0 | Not in Canada |
| Diphenylpyraline, Combinations | JAMP-COUGH SUPPOSITORIES ADULT | 1 | 0 | Not in Canada |
| Doxylamine | UNISOM-2 TABLETS | 1 | 0 | Not in Canada |
| Dimenhydrinate, Combinations | GRAVERGOL CAPSULES | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC R06A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| R06AX | Astemizole · Azatadine · Bilastine · Cyproheptadine · Desloratadine · +6 more | 84 | 38 |
| R06AE | Cetirizine · Cyclizine · Meclozine · Meclozine, Combinations | 69 | 27 |
| R06AB | Brompheniramine · Chlorpheniramine · Dexchlorpheniramine | 17 | 1 |
| R06AD | Alimemazine · Promethazine | 17 | 1 |
| R06AC | Tripelennamine | 1 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is TRAVAMINE TAB 50MG called?
The same molecule, Dimenhydrinate, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Vertirosan Tropf. | Latin | Austria |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
What is Dimenhydrinate called in other languages?
Buyers, prescribers and procurement teams outside Canada often search for the ingredient in their own script. These are phonetic renderings of the ingredient name Dimenhydrinate, published to help those searches reach this page.
| Language | Dimenhydrinate |
|---|---|
| Arabic العربية | ديمينهيدرينات |
| Spanish Español | Dimenhidrinato |
| Portuguese Português | Dimenidrinato |
| German Deutsch | Dimenhydrinat |
| Italian Italiano | Dimenidrinato |
These are transliterations of the ingredient name, generated automatically and published only where two independent checks agreed. They are not registered local trade names and carry no marketing authorisation in any market. Always confirm a product against its local registration before ordering.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.